• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 4. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Nitroquinolines and derivatives

Introduction to 8-Ethoxy-5-nitroquinoline (CAS No. 19746-57-7) and Its Emerging Applications in Chemical Biology

8-Ethoxy-5-nitroquinoline, identified by the Chemical Abstracts Service Number (CAS No.) 19746-57-7, is a heterocyclic organic compound that has garnered significant attention in the field of chemical biology due to its unique structural and pharmacological properties. This compound belongs to the quinoline family, which is well-documented for its broad spectrum of biological activities, including antimicrobial, antimalarial, and anticancer effects. The presence of both ethoxy and nitro substituents in the molecule imparts distinct electronic and steric characteristics, making it a versatile scaffold for drug discovery and mechanistic studies.

Theethoxy group at the 8-position enhances the lipophilicity of the quinoline core, facilitating better cell membrane penetration, while thenitro group at the 5-position introduces a polar region that can interact with biological targets through hydrogen bonding or electrostatic interactions. This dual functionality has been exploited in recent years to develop novel bioactive molecules with improved pharmacokinetic profiles.

In recent years, 8-Ethoxy-5-nitroquinoline has been extensively studied for its potential as an intermediate in the synthesis of bioactive derivatives. Researchers have leveraged its structural framework to explore novel therapeutic agents targeting various diseases. One notable area of investigation has been its role in developing inhibitors of kinases and other enzymes implicated in cancer progression. The nitro group, in particular, has been shown to serve as a handle for redox-sensitive drug design, allowing for controlled release of active species within tumor microenvironments.

Furthermore, theethoxy-substituted quinoline scaffold has been investigated for its antimicrobial properties. Studies have demonstrated that derivatives of 8-Ethoxy-5-nitroquinoline exhibit potent activity against multidrug-resistant bacterial strains by interfering with bacterial DNA gyrase and topoisomerase functions. This mechanism aligns with the growing global concern over antibiotic resistance, making such compounds highly relevant for future therapeutic strategies.

Thenitro group also plays a crucial role in photodynamic therapy (PDT) applications. When exposed to light, nitro-containing compounds can generate reactive oxygen species (ROS), which are cytotoxic to target cells. This property has been explored in the development of photosensitizer-based treatments for cancer and inflammatory diseases. Recent advances in PDT using 8-Ethoxy-5-nitroquinoline derivatives have shown promising results in preclinical studies, highlighting its potential as a non-invasive therapeutic modality.

From a synthetic chemistry perspective, 8-Ethoxy-5-nitroquinoline serves as a valuable building block for constructing more complex molecules. Its reactivity allows for facile functionalization at multiple positions, enabling the creation of libraries of analogs with tailored biological activities. Techniques such as nucleophilic aromatic substitution and metal-catalyzed cross-coupling reactions have been employed to introduce diverse substituents while preserving the core quinoline structure.

The compound’sethoxy group also contributes to its solubility profile, making it amenable to formulation into various delivery systems. This characteristic is particularly important for oral and topical applications, where bioavailability is a critical factor. Researchers have explored nanocarrier-based delivery systems encapsulating 8-Ethoxy-5-nitroquinoline to enhance its absorption and target specificity.

In conclusion, 8-Ethoxy-5-nitroquinoline (CAS No. 19746-57-7) represents a promising candidate for further exploration in medicinal chemistry and chemical biology. Its unique structural features offer multiple avenues for drug development across various therapeutic domains. As research continues to uncover new applications for this compound and its derivatives, it is likely to remain a cornerstone in academic and industrial investigations aimed at addressing unmet medical needs.

• 88757-62-4(Propanenitrile, 2-[(5-nitro-8-quinolinyl)oxy]-)
• 32951-76-1(5-methoxy-3-nitro-9-phenoxyacridine)
• 116253-76-0(Quinoline, 8-(4-nitrophenoxy)-)
• 80912-11-4(Quinoline, 8-methoxy-6-nitro-)
• 175913-32-3(7-Methoxy-4-nitro-1H-indole)
• 916756-95-1(3-ethoxy-6-nitro-1H-Indole)
• 4008-48-4(Nitroxoline)
• 88757-90-8(Acetonitrile, [(5-nitro-8-quinolinyl)oxy]-)
• 17012-47-4(8-Methoxy-5-nitroquinoline)
• 20304-70-5(2-ethoxy-6-nitroacridin-9-amine)